[1]
M. Jumayev, “THE EFFECTS OF GLUCAGON-LIKE PEPTIDE-1 AGONIST THERAPY (SEMAGLUTIDE AND TIRZEPATIDE) ON METABOLIC AND HORMONAL PARAMETERS IN MEN WITH OBESITY AND INSULIN RESISTANCE”, ICHT, vol. 2, no. 2, pp. 165–167, Mar. 2026, doi: 10.5281/zenodo.18824751.